Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Why this trial matters: First large Phase III evidence of biopsy-confirmed histologic benefit with a metabolic drug in MASH Demonstrates semaglutides impact beyond weight loss to disease-modifying liver effects Supports expanding GLP-1 therapeutics into liver disease care amid a high unmet need Ianalumab Meets Endpoints in Phase III Sjgrens Disease Trials (NEPTUNUS-1 & 2) Novartis reported that both Phase III studies of ianalumab achieved their primary endpoints in patients with Sjgrens disease, offering the first targeted therapy with statistically significant disease activity reduction in this chronic autoimmune disorder
Storage: As a reconstituted injectable, DSIP should be stored in a cold, dry place
Establish a systematic rotation pattern, such as: Week 1: Right abdomen Week 2: Left abdomen Week 3: Right thigh Week 4: Left thigh Week 5: Right upper arm Week 6: Left upper arm Week 7: Return to right abdomen This approach ensures each site receives adequate recovery time between injections
HCPCS J-code for medication
US$ 23.12
US$ 28.21
US$ 27.51
US$ 20.50
